Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Routine use of expensive hemostatic agents during RALPN does not seem to be justified. The use of hemostatic agents (HAs) during standard robotic-assisted laparoscopic partial nephrectomy (RALPN) does ...

Neurable research scientist Alicia Howell-Munson demonstrates the company's headset, which it says can detect early signs of Alzheimer's disease - Copyright AFP ...

Specialization plays a decisive role in long-term earning potential. High-demand areas like corporate law, tax law, and intellectual property lawyers’ work can provide both stability and upward ...

Abstract: Approximate hardware trades acceptable error for improved performance and previous literature focuses on optimizing this tradeoff in the hardware. We show ...

Lenvima and Keytruda with chemotherapy did not significantly improve OS in metastatic ESCC compared to Keytruda and chemotherapy alone. Median OS was 17.6 months in the Lenvima arm versus 15.5 months ...

An expert discusses how the phase 3 LUNA 3 trial demonstrated that rilzabrutinib achieved durable platelet responses in 23% of patients while also being the first prospective trial to show significant ...

A recent study challenges the routine use of adjunctive dexmedetomidine for pain management in ICU patients with traumatic rib fractures, finding no significant benefit over standard care. A recent ...

Abstract: Combinatorial optimization is a promising area for achieving quantum speedup. The quantum approximate optimization algorithm (QAOA) is designed to search for low-energy states of the Ising ...

While air traffic controllers welcome an infusion of more than $12 billion to modernize their equipment, some controllers say they are under pressure due to other issues, such as grueling schedules, ...

In low-risk pregnant women with penicillin allergy, direct challenges with amoxicillin were as safe as penicillin skin testing while offering shorter completion times at a lower cost. Researchers ...